Like other CRL1 interacting proteins, FBXL10 role in cancer seems to be tissue specific in humans with higher levels of FBXL10 observed in several types of cancers while it is downregulated in brain tumors (Frescas et al., 2007; Tzatsos et al., 2013). This evidence concerns the gene KDM2B and cancer.